Cedars-Sinai
companyCedars-Sinai conducts pioneering research in space medicine and biomedicine.
Cedars-Sinai is advancing space medicine through its Center for Space Medicine Research, collaborating with Exobiosphere to automate biomedical research in space. The institution has participated in multiple NASA missions, including sending organoids to the International Space Station. Cedars-Sinai is also involved in experiments aboard the upcoming Haven-1 commercial space station, developed by Vast.
Articles · 1
view in feed →
Vast and Cedars-Sinai Partner on Microgravity Science and Crew Health with Upcoming Mission aboard ‘Haven-1’
Vast has formed a strategic partnership with Cedars-Sinai to advance microgravity science and crew health aboard the upcoming Haven-1 commercial space station, scheduled for launch in 2027. This collaboration will focus on stem cell and organoid research, alongside biomanufacturing technology demonstrations, aimed at enhancing regenerative medicine, longevity, and disease modeling in microgravity environments.